Complete Up To Date Information about Hydeltrone-TBA Suspension.
NADA Number: 011-080 | |
| Proprietary Name |
Hydeltrone-TBA Suspension |
|---|---|
| Sponsor |
Merial Ltd. |
| Sponsor Address |
3239 Satellite Blvd. Bldg. 500 Duluth, GA 30096-4640 USA |
| Ingredients |
Prednisolone Tertiary Butylacetate |
| Species |
Cat, restricted during pregnancy Dog, restricted during pregnancy Horse, restricted during pregnancy |
| Routes of Administration |
Intrasynovial Intramuscular |
| Dose Form |
Liquid (suspension) |
| Drug Form |
Liquid (suspension) |
| Dispensing Status |
RX |
|
Dosage Amount, Indications & Limitations |
522.1885 Prednisolone tertiary butylacetate suspension. Specifications: Prednisolone tertiary butylacetate suspension contains 20 milligrams of prednisolone tertiary butylacetate per milliliter. It is sterile. Conditions of use: Horses Amount: It is administered to horses intramuscularly at a dosage level of 100 to 300 milligrams and intrasynovially at a dosage level of 50 to 100 milligrams. Intramuscular re-treatment of horses in 24 to 48 hours may be necessary, depending on the general condition of the animal and the severity and duration of the disease. Indications: It is used as an anti-inflammatory agent in horses. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered late in pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Dogs Amount: It is administered intramuscularly to dogs at a dosage level of 1 milligram per 5 pounds of body weight and intrasynovially at a dosage level of 10 to 20 milligrams. Indications: It is used as an anti-inflammatory agent in dogs. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered late in pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Cats Amount: It is administered intramuscularly to cats at a dosage level of 1 milligram per 5 pounds of body weight and intrasynovially at a dosage level of 10 to 20 milligrams. Indications: It is used as an anti-inflammatory agent in cats. Limitations: Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered late in pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. NAS/NRC status: These conditions are NAS/NRC reviewed and found effective. Applications for these uses need not include effectiveness data as specified by 514.111 of this chapter, but may require bioequivalency and safety information. |
| Tolerances |
A tolerance of zero is established for residues of prednisolone in milk from dairy animals. |